早期使用纳洛酮与不可除颤院外心脏骤停结局的关联
本研究为波特兰心脏骤停流行病学登记数据库的二次分析,纳入2018至2021年1807例初始不可除颤心律的非创伤性院外心脏骤停患者,其中57例在静脉/骨内通路建立前接受纳洛酮。多因素logistic回归调整年龄、性别、骤停地点、目击状态、旁观者干预、派遣至EMS到达时间、初始心律及骤停所在县后,纳洛酮组任何时间ROSC的aOR为2.14(95%CI 1.20-3.81),到达急诊科时ROSC的aOR为2.14(95%CI 1.18-3.88),存活至入院aOR为2.86(95%CI 1.60-5.09),存活至出院aOR为4.41(95%CI 1.78-10.97),出院时脑功能分类评分≤2的aOR为4.61(95%CI 1.74-12.19)。作者结论认为,在静脉/骨内通路尝试前接受执法部门或EMS纳洛酮与上述结局的更高调整比值比相关。
要点
- 初始不可除颤心律的院外心脏骤停患者,在静脉/骨内通路建立前接受纳洛酮,任何时间ROSC的aOR为2.14(95%CI 1.20-3.81)。
- 到达急诊科时ROSC的aOR为2.14(95%CI 1.18-3.88),存活至入院aOR为2.86(95%CI 1.60-5.09)。
- 存活至出院aOR为4.41(95%CI 1.78-10.97),出院时脑功能分类评分≤2的aOR为4.61(95%CI 1.74-12.19)。
- 共1807例符合标准,仅57例在血管通路建立前接受纳洛酮,暴露组样本量小。
适用人群与场景
- 非创伤性院外心脏骤停且初始心律为不可除颤心律的患者,来自波特兰心脏骤停流行病学登记数据库中2018至2021年EMS治疗的病例。
- 暴露组为在静脉/骨内通路建立前接受EMS或执法部门给予纳洛酮的患者。
研究设计与关键结果
- 研究类型为波特兰心脏骤停流行病学登记数据库的二次分析,纳入2018至2021年1807例符合标准的初始不可除颤心律非创伤性院外心脏骤停患者,其中57例在静脉/骨内通路建立前接受纳洛酮。
- 主要终点为到达急诊科时ROSC:纳洛酮组调整后比值比aOR 2.14(95%CI 1.18-3.88)。
- 关键次要终点:任何时间ROSC aOR 2.14(95%CI 1.20-3.81);存活至入院aOR 2.86(95%CI 1.60-5.09);存活至出院aOR 4.41(95%CI 1.78-10.97);出院时脑功能分类评分≤2 aOR 4.61(95%CI 1.74-12.19)。
- 多因素logistic回归调整了年龄、性别、骤停地点、目击状态、旁观者干预、派遣至EMS到达时间、初始心律及骤停所在县。
证据类型、等级与局限
- 证据类型:登记数据库的二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,初始不可除颤心律的院外心脏骤停患者若在静脉/骨内通路尝试前接受执法部门或EMS纳洛酮,与更高的任何时间ROSC、到达急诊科时ROSC、存活至入院、存活至出院及良好神经结局的调整比值比相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
STUDY OBJECTIVE: Evaluate the association between early naloxone use and outcomes after out-of-hospital cardiac arrest (OHCA) with initial non-shockable rhythms.
METHODS: This study was a secondary analysis of data collected in the Portland Cardiac Arrest Epidemiologic Registry, a database containing details of emergency medical services (EMS)-treated OHCA cases in the Portland, Oregon metropolitan region. Eligible patients had non-traumatic OHCA with an initial non-shockable rhythm and received naloxone by EMS or law enforcement prior to IV/IO access (exposure group). The primary outcome was ROSC at emergency department (ED) arrival. Secondary outcomes included survival to admission, survival to hospital discharge, and cerebral performance category score ≤2 at discharge (good neurologic outcome). We performed multivariable logistic regressions adjusting for age, sex, arrest location, witness status, bystander interventions, dispatch to EMS arrival time, initial rhythm, and county of arrest.
RESULTS: There were 1807 OHCA cases from 2018 to 2021 meeting eligibility criteria, with 57 receiving naloxone before vascular access. Patients receiving naloxone prior to vascular access attempts had higher adjusted odds (aOR [95% CI]) of ROSC at any time (2.14 [1.20-3.81]), ROSC at ED arrival (2.14 [1.18-3.88]), survival to admission (2.86 [1.60-5.09]), survival to discharge (4.41 [1.78-10.97]), and good neurologic outcome (4.61 [1.74-12.19]).
CONCLUSIONS: Patients with initial non-shockable OHCA who received law enforcement or EMS naloxone prior to IV/IO access attempts had higher adjusted odds of ROSC at any time, ROSC at ED arrival, survival to admission, survival to discharge, and good neurologic outcome.
参考来源
- Strong NH, Daya MR, Neth MR, et al. The association of early naloxone use with outcomes in non-shockable out-of-hospital cardiac arrest. Resuscitation. 2024. PMID: 38848964. doi:10.1016/j.resuscitation.2024.110263
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。